Background and summary: Among all vulvar cancers, primary adenoid cystic carcinoma (ACC) of Bartholin’s gland is a very rare tumor characterized by a slow growth, a high local aggressiveness, and a remarkable recurrence rate. Due to its rarity, treatment remains a challenge for oncologists and gynecological surgeons. Key message: The present paper reports clinical, radiological, and histological features of ACC of Bartholin’s gland and reviews the literature data on the treatment options with a particular focus on the potential role of particle radiation therapy.

1.
da Cruz Perez
DE
,
de Abreu Alves
F
,
Nobuko Nishimoto
I
,
de Almeida
OP
,
Kowalski
LP
.
Prognostic factors in head and neck adenoid cystic carcinoma
.
Oral Oncol
.
2006
;
42
:
139
46
.
2.
van Weert
S
,
Bloemena
E
,
van der Waal
I
,
de Bree
R
,
Rietveld
DH
,
Kuik
JD
, et al.
Adenoid cystic carcinoma of the head and neck: a single-center analysis of 105 consecutive cases over a 30-year period
.
Oral Oncol
.
2013
;
49
:
824
9
.
3.
Ellington
CL
,
Goodman
M
,
Kono
SA
,
Grist
W
,
Wadsworth
T
,
Chen
AY
, et al.
Adenoid cystic carcinoma of the head and neck: incidence and survival trends based on 1973–2007 Surveillance, Epidemiology, and End Results data
.
Cancer
.
2012
;
118
:
4444
51
.
4.
Chae
YK
,
Chung
SY
,
Davis
AA
,
Carneiro
BA
,
Chandra
S
,
Kaplan
J
, et al.
Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling
.
Oncotarget
.
2015 Nov 10
;
6
(
35
):
37117
34
.
5.
Hwang
TLC
,
Hung
YC
,
Chang
HW
.
Adenoid cystic carcinoma of Bartholin’s gland
.
Taiwan J Obstet Gynecol
.
2012 Mar
;
51
(
1
):
119
20
.
6.
Lee
MY
,
Dalpiaz
A
,
Schwamb
R
,
Miao
Y
,
Waltzer
W
,
Khan
A
.
Clinical pathology of Bartholin’s glands: a review of the literature
.
Curr Urol
.
2015
;
8
(
1
):
22
5
.
7.
Copeland
LJ
,
Sneige
N
,
Gershenson
DM
,
McGuffee
VB
,
Abdul-Karim
F
,
Rutledge
FN
.
Bartholin gland carcinoma
.
Obstet Gynecol
.
1986
;
67
:
794
801
.
8.
Xing
D
,
Bakhsh
S
,
Melnyk
N
,
Isacson
C
,
Ho
J
,
Huntsman
DG
, et al.
Frequent NFIB-associated gene rearrangement in adenoid cystic carcinoma of the vulva
.
Int J Gynecol Pathol
.
2017 May
;
36
(
3
):
289
93
.
9.
Moskaluk
CA
.
Adenoid cystic carcinoma: clinical and molecular features
.
Head neck Pathol
.
2013
;
7
:
17
22
.
10.
Su
BH
,
Qu
J
,
Song
M
,
Huang
XY
,
Hu
XM
,
Xie
J
, et al.
NOTCH1 signaling contributes to cell growth,anti-apoptosis and metastasis in salivary adenoid cystic carcinoma
.
Oncotarget
.
2014 Aug 30
;
5
(
16
):
6885
95
.
11.
Stephens
PJ
,
Davies
HR
,
Mitani
Y
,
Van Loo
P
,
Shlien
A
,
Tarpey
PS
, et al.
Whole exome sequencing of adenoid cystic carcinoma
.
J Clin Invest
.
2013
;
123
:
2965
8
.
12.
Yang
X
,
Jing
D
,
Liu
L
,
Shen
Z
,
Ju
J
,
Ma
C
, et al.
Downregulation of p53 promotes in vitro perineural invasive activity of human salivary adenoid cystic carcinoma cells through epithelial-mesenchymal transition-like changes
.
Oncol Rep
.
2015
;
33
:
1650
6
.
13.
Costa
AF
,
Altemani
A
,
Vekony
H
,
Bloemena
E
,
Fresno
F
,
Suarez
C
, et al.
Genetic profile of adenoid cystic carcinomas (ACC) with high-grade transformation versus solid type
.
Anal Cell Pathol (Amst)
.
2010
;
33
:
217
28
.
14.
Cardosi
KJ
,
Speights
A
,
Fiorica
JV
,
Grendys
EC
. Jr
,
Hakam
A
,
Hoffman
MS
.
Bartholin’s gland carcinoma: a 15-year experience
.
Gynecol Oncol
.
2001
;
82
:
247
51
.
15.
Finan
MA
,
Barre
G
.
Bartholin’s gland carcinoma, malignant melanoma and other rare tumours of the vulva
.
Best Pract Res Clin Obstet Gynaecol
.
2003 Aug
;
17
(
4
):
609
33
.
16.
Goh
SP
,
McCully
B
,
Wagner
MK
.
A case of adenoid cystic carcinoma mimicking a Bartholin cyst and literature review
.
Case Rep Obstet Gynecol
.
2018
;
2018
:
3
.
17.
Bhalwal
AB
,
Nick
AM
,
Dos Reis
R
,
Chen
CL
,
Munsell
MF
,
Ramalingam
P
, et al.
Carcinoma of the Bartholin gland: a review of 33 cases
.
Int J Gynecol Cancer
.
2016
;
26
(
4
):
785
9
.
18.
Akbarzadeh-Jahromi
M
,
Aslani
FS
,
Omidifar
N
,
Amooee
S
.
Adenoid cystic carcinoma of bartholin’s gland clinically mimics endometriosis, A case report
.
Iran J Med Sci
.
2014
;
39
(
6
):
580
3
.
19.
Tonev
ID
,
Pirgova
YS
,
Conev
NV
.
Primary adenoid cystic carcinoma of the skin with multiple local recurrences
.
Case Rep Oncol
.
2015
;
8
(
2
):
251
5
.
20.
Hsu
ST
,
Wang
RC
,
Lu
CH
,
Ke
YM
,
Chen
YT
,
Chou
MM
, et al.
Report of two cases of adenoid cystic carcinoma of Bartholin’s gland and review of literature
.
Taiwan J Obstet Gynecol
.
2013 Mar
;
52
(
1
):
113
6
.
21.
Yoon
G
,
Kim
HS
,
Lee
YY
,
Kim
TJ
,
Choi
CH
,
Song
SY
, et al.
Analysis of clinical outcomes of patients with adenoid cystic carcinoma of Bartholin glands
.
Int J Clin Exp Pathol
.
2015 May 1
;
8
(
5
):
5688
94
.
22.
Johnson
LR
,
Nair
RP
,
Sambasivan
S
,
Mony
RP
,
Gangadharan
J
,
Kumar
A
, et al.
Adenoid cystic carcinoma of vulva-11 years’ single-institution experience
.
J Obstet Gynaecol India
.
2017
;
67
(
3
):
196
201
.
23.
Yang
SY
,
Lee
JW
,
Kim
WS
,
Jung
KL
,
Lee
SJ
,
Lee
JH
, et al.
Adenoid cystic carcinoma of the Bartholin’s gland: report of two cases and review of the literature
.
Gynecol Oncol
.
2006 Feb
;
100
(
2
):
422
5
.
24.
Sisodia
SM
,
Khan
WAZA
,
Ansari
SAH
,
Mahajan
V
.
Adenoid cystic carcinoma of Bartholin′s gland: report of a case and review of literature
.
South Asian J Cancer
.
2013
;
2
(
1
).
25.
Momeni
M
,
Korotkaya
Y
,
Carrasco
G
,
Prasad-Hayes
M
.
Adenoid cystic carcinoma of Bartholin’s gland: case report
.
Acta Med Iranica
.
2016
;
54
(
12
):
820
2
.
26.
Woida
FM
,
Ribeiro-Silva
A
.
Adenoid cystic carcinoma of the bartholin gland: an overview
.
Arch Pathol Lab Med
.
2007
;
131
(
5
):
796
8
.
27.
Nasu
K
,
Kawano
Y
,
Takai
N
,
Kashima
K
,
Miyakawa
I
.
Adenoid cystic carcinoma of Bartholin’s gland: case report with review of the literature
.
Gynecol Obstet Invest
.
2005
;
59
(
1
):
54
8
.
28.
Makhija
A
,
Desai
AD
,
Patel
BM
,
Parekh
CD
.
Adenoid cystic carcinoma of bartholin’s gland misdiagnosed as benign vulvar adnexal tumour
.
Indian J Gynecol Oncol
.
2018
;
16
(
1
):
1
.
29.
Zhan
P
,
Li
G
,
Liu
B
,
Mao
X-G
.
Bartholin gland carcinoma: a case report
.
Oncol Lett
.
2014
;
8
(
2
):
849
51
.
30.
Downs
LS
,
Gosh
K
,
Dusenbery
KE
,
Cosin
JA
.
Stage IV carcinoma of the BG managed with primary chemoradiation
.
Gynecol Oncol
.
2002
;
87
(
2
):
210
2
.
31.
Cassio
A
,
Pellizzon
A
.
The adenoid cystic carcinoma of the Bartholin’s gland: a literature review
.
Appl Cancer Res
.
2012
;
38
:
6
.
32.
Ouldamer
L
,
Chraibi
Z
,
Arbion
F
,
Barillot
I
,
Body
G
.
Bartholin’s gland carcinoma: epidemiology and therapeutic management
.
Surg Oncol
.
2013 Jun
;
22
(
2
):
117
22
.
33.
Di Donato
V
,
Casorelli
A
,
Bardhi
E
,
Vena
F
,
Marchetti
C
,
Muzii
L
, et al.
Bartholin gland cancer
.
Crit Rev Oncol Hematol
.
2017 Sep
;
117
:
1
11
.
34.
Benhayoune
K
,
El Fatemi
H
,
Bannani
A
,
Melhouf
A
,
Harmouch
T
.
Adenoid cystic carcinoma of cervix: two cases report and review of the literature
.
Pan Afr Med J
.
2015
;
20
:
77
.
35.
Dellinger
TH
,
Hakim
AA
,
Lee
SJ
,
Wakabayashi
MT
,
Morgan
RJ
,
Han
ES
.
Surgical management of vulvar cancer
.
J Natl Compr Canc Netw
.
2017
;
150
:
121
8
.
36.
Benedet
JL
,
Bender
H
,
Jones
H
, 3rd
,
Ngan
HY
,
Pecorelli
S
.
FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers: FIGO Committee on Gynecologic Oncology
.
Int J Gynaecol Obstet
.
2000
;
70
:
209
62
.
37.
Micheletti
L
,
Preti
M
.
Surgery of the vulva in vulvar cancer
.
Best Pract Res Clin Obstet Gynaecol
.
2014
;
7
:
1074
87
.
38.
Leuchter
RS
,
Hacker
NF
,
Voet
RL
,
Berek
JS
,
Townsend
DE
,
Lagasse
LD
.
Primary carcinoma of the Bartholin gland: a report of 14 cases and review of the literature
.
Obstet Gynecol
.
1982
;
60
:
361
8
.
39.
Homesley
HD
,
Bundy
BN
,
Sedlis
A
,
Adcock
L
.
Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes
.
Obstet Gynecol
.
1986
;
68
:
733
40
.
40.
Kunos
C
,
Simpkins
F
,
Gibbons
H
,
Tian
C
,
Homesley
H
.
Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial
.
Obstet Gynecol
.
2009 Sep
;
114
(
3
):
537
46
.
41.
Khan
AJ
,
DiGiovanna
MP
,
Ross
DA
,
Sasaki
CT
,
Carter
D
,
Son
YH
, et al.
Adenoid cystic carcinoma: a retrospective clinical review
.
Int J Cancer
.
2001 Jun 20
;
96
(
3
):
149
58
.
42.
Oplatek
A
,
Ozer
E
,
Agrawal
A
,
Bapna
S
,
Schuller
DE
.
Patterns of recurrence and survival of head and neck adenoid cystic carcinoma after definitive resection
.
Laryngoscope
.
2010
;
120
:
65
70. 11
.
43.
Lee
SY
,
Kim
BH
,
Choi
EC
.
Nineteen-year oncologic outcomes and the benefit of elective neck dissection in salivary gland adenoid cystic carcinoma
.
Head Neck
.
2014
;
36
:
1796
801
.
44.
Cordesmeyer
R
,
Kauffmann
P
,
Laskawi
R
,
Rau
A
,
Bremmer
F
.
The incidence of occult metastasis and the status of elective neck dissection in salivary adenoid cystic carcinoma: a single center study
.
Oral Surg Oral Med Oral Pathol Oral Radiol
.
2018 Jun
;
125
(
6
):
516
9
.
45.
Min
R
,
Siyi
L
,
Wenjun
Y
,
Ow
A
,
Lizheng
W
,
Minjun
D
, et al.
Salivary gland adenoid cystic carcinoma with cervical lymph node metastasis: a preliminary study of 62 cases
.
Int J Oral Maxillofac Surg
.
2012 Aug
;
41
(
8
):
952
7
.
46.
Fordice
J
,
Kershaw
C
,
El-Naggar
A
,
Goepfert
H
.
Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality
.
Arch Otolaryngol Head Neck Surg
.
1999
;
125
:
149
52. 16
.
47.
Gomez
DR
,
Hoppe
BS
,
Wolden
SL
,
Zhung
JE
,
Patel
SG
,
Kraus
DH
, et al.
Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience
.
Int J Radiat Oncol Biol Phys
.
2008 Apr 1
;
70
(
5
):
1365
72
.
48.
Anaf
V
,
Buxant
F
,
Rodesch
F
,
Simon
P
,
van de Stadt
J
,
Noel
JC
, et al.
Adenoid cystic carcinoma of Bartholin’s gland: what is the optimal approach?
Eur J Surg Oncol
.
1999 Aug
;
25
(
4
):
406
9
.
1999
.
49.
Almeida
LO
,
Guimarães
DM
,
Martins
MD
,
Martins
MAT
,
Warner
KA
,
Nör
JE
, et al.
Unlocking the chromatin of adenoid cystic carcinomas using HDAC inhibitors sensitize cancer stem cells to cisplatin and induces tumor senescence
.
Stem Cell Res
.
2017 May
;
21
:
94
105
.
50.
Massad
LS
,
De Geest
K
.
Multimodality therapy for carcinoma of the Bartholin gland
.
Gynecol Oncol
.
1999
;
75
:
305
7
.
51.
De Dosso
S
,
Mazzucchelli
L
,
Ghielmini
M
,
Saletti
P
.
Response to oxaliplatin with cetuximab in minor salivary gland adenoid cystic carcinoma
.
Tumori
.
2009
;
95
(
3
):
378
81
.
52.
Shoji
T
,
Takatori
E
,
Omi
H
,
Kumagai
S
,
Yoshizaki
A
,
Yokoyama
Y
.
Phase II clinical study of the combination chemotherapy regimen of irinotecan plus oral etoposide for the treatment of recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 101 Group Study)
.
Int J Gynecol Cancer
.
2011
;
21
(
1
):
44
50
.
53.
Takatori
E
,
Shoji
T
,
Miura
J
,
Takeuchi
S
,
Sugiyama
T
.
Chemoradiotherapy with irinotecan (CPT-11) for adenoid cystic carcinoma of Bartholin’s gland: a case report and review of the literature
.
Gynecol Oncol Case Rep
.
2012 Dec 14
;
4
:
16
9
.
54.
Sugiyama
T
,
Nishida
T
,
Hosokawa
Y
,
Ushijima
H
,
Nishimura
H
,
Umezu
J
.
Adenoid cystic carcinoma of Bartholin’s gland. A review of the literature and report of a patient
.
Acta Obstet Gynaecol Jpn
.
1984
;
36
(
5
):
829
32
.
55.
Alsan
CI
,
Vinh-Hung
V
,
Eren
F
,
Abacioğlu
U
.
Adenoid cystic carcinoma of the Bartholin’s gland: case report and systematic review of the literature
.
Eur J Gynaecol Oncol
.
2011
;
32
(
5
):
567
72
.
56.
Rosenberg
P
,
Simonsen
E
,
Risberg
B
.
Adenoid cystic carcinoma of Bartholin’s gland: a report of five new cases treated with surgery and radiotherapy
.
Gynecol Oncol
.
1989
;
34
:
145
7
.
57.
Laramore
GE
,
Krall
JM
,
Griffin
TW
,
Duncan
W
,
Richter
MP
,
Saroja
KR
, et al.
Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council
.
Int J Radiat Oncol Biol Phys
.
1993 Sep 30
;
27
(
2
):
235
40
.
58.
Huber
PE
,
Debus
J
,
Latz
D
,
Zierhut
D
,
Bischof
M
,
Wannenmacher
M
, et al.
Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam?
Radiother Oncol
.
2001 May
;
59
(
2
):
161
7
.
59.
Pommier
P
,
Liebsch
NJ
,
Deschler
DG
,
Lin
DT
,
McIntyre
JF
,
Barker
FG
, 2nd
, et al.
Proton beam radiation therapy forskull base adenoid cystic carcinoma
.
Arch Otolaryngol Head Neck Surg
.
2006 Nov
;
132
(
11
):
1242
9
.
60.
Mizoe
JE
,
Tsujii
H
,
Kamada
T
,
Matsuoka
Y
,
Tsuji
H
,
Osaka
Y
, et al.,
Organizing Committee for the Working Group for Head-And-Neck Cancer
.
Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer
.
Int J Radiat Oncol Biol Phys
.
2004 Oct 1
;
60
(
2
):
358
64
.
61.
Durante
M
,
Loeffler
JS
.
Charged particles in radiation oncology
.
Nat Rev Clin Oncol
.
2010
;
7
:
37
43
.
62.
Barcellini
A
,
Vitolo
V
,
Facoetti
A
,
Fossati
P
,
Preda
L
,
Fiore
MR
, et al.
Feasibility of carbon ion radiotherapy in the treatment of gynecological melanoma
. In
Vivo
.
2019 Mar-Apr
;
33
(
2
):
473
6
.
63.
Wang
L
,
Wang
X
,
Zhang
Q
,
Ran
J
,
Geng
Y
,
Feng
S
, et al.
Is there a role for carbon therapy in the treatment of gynecological carcinomas? A systematic review
.
Future Oncol
.
2019 Sep
;
15
(
26
):
3081
95
.
64.
Okonogi
N
,
Wakatsuki
M
,
Kato
S
,
Shiba
S
,
Kobayashi
D
,
Kiyohara
H
, et al.,
WORKING GROUP OF GYNECOLOGICAL TUMORS
.
Long-term outcomes of carbon-ion radiotherapy for locally advanced squamous cell carcinoma of the uterine cervix
.
Anticancer Res
.
2018 Jan
;
38
(
1
):
457
63
.
65.
Wakatsuki
M
,
Kato
S
,
Kiyohara
H
,
Ohno
T
,
Karasawa
K
,
Tamaki
T
, et al.,
Working Group of the Gynecological Tumor
.
Clinical trial of prophylactic extended-field carbon-ion radiotherapy for locally advanced uterine cervical cancer (protocol 0508)
.
PLoS One
.
2015 May 20
;
10
(
5
):
e0127587
.
66.
Shiba
S
,
Wakatsuki
M
,
Kato
S
,
Ohno
T
,
Okonogi
N
,
Karasawa
K
, et al.,
The Working Group of the Gynecological Tumor
.
Carbon-ion radiotherapy for locally advanced cervical cancer with bladder invasion
.
J Radiat Res
.
2016 Nov
;
57
(
6
):
684
90
.
67.
Mori
S
,
Shibayama
K
,
Tanimoto
K
,
Kumagai
M
,
Matsuzaki
Y
,
Furukawa
T
, et al.
First clinical experience in carbon ion scanning beam therapy: retrospective analysis of patient positional accuracy
.
J Radiat Res
.
2012 Sep
;
53
(
5
):
760
8
.
68.
Ohno
T
,
Noda
SE
,
Murata
K
,
Yoshimoto
Y
,
Okonogi
N
,
Ando
K
, et al.,
Working Group for Gynecologic Cancer
.
Phase I study of carbon ion radiotherapy and image-guided brachytherapy for locally advanced cervical cancer
.
Cancers (Basel)
.
2018 Sep 18
;
10
(
9
):
338
.
69.
Wakatsuki
M
,
Kato
S
,
Ohno
T
,
Karasawa
K
,
Ando
K
,
Kiyohara
H
, et al.,
Working Group of the Gynecological Tumor
.
Dose-escalation study of carbon ion radiotherapy for locally advanced squamous cell carcinoma of the uterine cervix (9902)
.
Gynecol Oncol
.
2014 Jan
;
132
(
1
):
87
92
.
70.
Irie
D
,
Okonogi
N
,
Wakatsuki
M
,
Kato
S
,
Ohno
T
,
Karasawa
K
, et al.,
and The Working Group of the Gynecological Tumor
.
Carbon-ion radiotherapy for inoperable endometrial carcinoma
.
J Radiat Res
.
2018 May 1
;
59
(
3
):
309
15
.
71.
Murata
H
,
Okonogi
N
,
Wakatsuki
M
,
Kato
S
,
Kiyohara
H
,
Karasawa
K
, et al.,
The Working Group Of Gynecological Tumors TWGOG
.
Long-term outcomes of carbon-ion radiotherapy for malignant gynecological melanoma
.
Cancers (Basel)
.
2019 Apr 4
;
11
(
4
):
482
.
72.
Bernhardt
D
,
Sterzing
F
,
Adeberg
S
,
Herfarth
K
,
Katayama
S
,
Foerster
R
, et al.
Bimodality treatment of patients with pelvic adenoid cystic carcinoma with photon intensity-modulated radiotherapy plus carbon ion boost: a case series
.
Cancer Manag Res
.
2018 Mar 26
;
10
:
583
8
. .
73.
Lelle
RJ
,
Davis
KP
,
Roberts
JA
.
Adenoid cystic carcinoma of the Bartholin’s gland: the University of Michigan experience
.
Int J Gynecol Cancer
.
1994 May
;
4
(
3
):
145
9
.
74.
Milchgrub
S
,
Wiley
EL
,
Vuitch
F
,
Albores-Saavedra
J
.
The tubular variant of adenoid cystic carcinoma of the Bartholin’s gland
.
Am J Clin Pathol
.
1994 Feb
;
101
(
2
):
204
8
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.